Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes

Clinical Microbiology and Infection

Volumn 22, Issue 6, 2016, Pages 570.e1-570.e9

  Jensen, R H ^a   Hagen, F ^b   Astvad, K M T ^a   Tyron, A ^a   Meis, J F ^b,c   Arendrup, M C ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillosis; azole resistance; CYP51A; genotyping; STRAf; TR34 L98H; TR46 Y121F T289A

Indexed keywords

BETA TUBULIN; PYRROLE DERIVATIVE; ANTIFUNGAL AGENT; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN; TUBULIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; DENMARK; FUNGAL STRUCTURES; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HEAT TOLERANCE; HUMAN; MOLECULAR PHYLOGENY; MYCOLOGY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT TANDEM REPEAT; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; DRUG EFFECTS; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DENMARK; DRUG RESISTANCE, FUNGAL; ENVIRONMENTAL MICROBIOLOGY; FUNGAL PROTEINS; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MICROBIOLOGICAL TECHNIQUES; RETROSPECTIVE STUDIES; TUBULIN;

EID: 84969667677     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.04.001     Document Type: Article

References (33)

1. [1] Vermeulen, E., Lagrou, K., Verweij, P.E., Azole resistance in Aspergillus fumigatus. Curr Opin Infect Dis 26 (2013), 493–500.
2. [2] Stensvold, C.R., Jørgensen, L.N., Arendrup, M.C., Azole-resistant invasive aspergillosis: relationship to agriculture. Curr Fungal Infect Rep 6 (2012), 178–191.
3. [3] van der Linden, J.W.M., Camps, S.M.T., Kampinga, G.A., Arends, J.P.A., Debets-Ossenkopp, Y.J., Haas, P.J.A., et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 57 (2013), 513–520.
4. [4] Snelders, E., Camps, S.M.T., Karawajczyk, A., Schaftenaar, G., Kema, G.H.J., van der Lee, H.A., et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One, 7, 2012, e31801.
5. [5] Abdolrasouli, A., Rhodes, J., Beale, M.A., Hagen, F., Rogers, T.R., Chowdhary, A., et al. Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing. MBio 6 (2015), 1–11.
6. [6] Peláez, T., Muñoz, P., Guinea, J., Valerio, M., Giannella, M., Klaassen, C.H.W., et al. Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. Clin Infect Dis 54 (2012), e24–31.
7. [7] Verweij, P.E., Chowdhary, A., Melchers, W.J.G., Meis, J.F., Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?. Clin Infect Dis 62 (2016), 362–368.
8. [8] Bowyer, P., Moore, C.B., Rautemaa, R., Denning, D.W., Richardson, M.D., Azole antifungal resistance today: focus on Aspergillus. Curr Infect Dis Rep 13 (2011), 485–491.
9. [9] Snelders, E., van der Lee, H.A.L., Kuijpers, J., Rijs, A.J.M.M., Varga, J., Samson, R.A., et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med, 5, 2008, e219.
10. [10] de Valk, H.A., Meis, J.F., Curfs, I.M., Muehlethaler, K., Mouton, J.W., Klaassen, C.H.W., Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol 43 (2005), 4112–4120.
11. [11] Klaassen, C.H.W., Gibbons, J.G., Fedorova, N.D., Meis, J.F., Rokas, A., Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. Mol Ecol 21 (2012), 57–70.
12. [12] Mortensen, K.L., Johansen, H.K., Fuursted, K., Knudsen, J.D., Gahrn-Hansen, B., Jensen, R.H., et al. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis 30 (2011), 1355–1363.
13. [13] Mortensen, K.L., Jensen, R.H., Johansen, H.K., Skov, M., Pressler, T., Howard, S.J., et al. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J Clin Microbiol 49 (2011), 2243–2251.
14. [14] Mortensen, K.L., Mellado, E., Lass-Flörl, C., Rodriguez-Tudela, J.L., Johansen, H.K., Arendrup, M.C., Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 54 (2010), 4545–4549.
15. [15] Astvad, K.M.T., Jensen, R.H., Hassan, T.M., Mathiasen, E.G., Thomsen, G.M., Pedersen, U.G., et al. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment. Antimicrob Agents Chemother 58 (2014), 5096–5101.
16. [16] de Hoog, G.S., Guarro, J., Gené, J., Figueras, M.J., (eds.) Atlas of clinical fungi, 2000, Centraalbureau voor Schimmelcultures (CBS), Utrecht.
17. [17] Glass, L.N., Donaldson, G.C., Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol 61 (1995), 1323–1330.
18. [18] De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C. Clin Infect Dis 46 (2008), 1813–1821.
19. [19] van der Linden, J.W.M., Arendrup, M.C., van der Lee, H.A., Melchers, W.J.G., Verweij, P.E., Azole containing agar plates as a screening tool for azole resistance of Aspergillus fumigatus. Mycoses, 52(Suppl. 1), 2009, S19.
20. [20] Arendrup, M.C., Cuenca-Estrella, M., Lass-Flörl, C., Hope, W., Howard, S.J., Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. Clin Microbiol Infect, 15, 2009, 103.
21. [21] Van Waeyenberghe, L., Pasmans, F., Beernaert, L.A., Haesebrouck, F., Vercammen, F., Verstappen F, et al. Microsatellite typing of avian clinical and environmental isolates of Aspergillus fumigatus. Avian Pathol 40 (2011), 73–77.
22. [22] Balajee, S.A., de Valk, H.A., Lasker, B.A., Meis, J.F., Klaassen, C.H.W., Utility of a microsatellite assay for identifying clonally related outbreak isolates of Aspergillus fumigatus. J Microbiol Methods 73 (2008), 252–256.
23. [23] Badali, H., Vaezi, A., Haghani, I., Yazdanparast, S.A., Hedayati, M.T., Mousavi, B., et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses 56 (2013), 659–663.
24. [24] de Valk, H.A., Klaassen, C.H.W., Yntema, J.B., Hebestreit, A., Seidler, M., Haase, G., et al. Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. J Cyst Fibros 8 (2009), 110–114.
25. [25] Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., Meis, J.F., Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J Antimicrob Chemother 69 (2014), 555–557.
26. [26] Tashiro, M., Izumikawa, K., Hirano, K., Ide, S., Mihara, T., Hosogaya, N., et al. Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus. Antimicrob Agents Chemother 56 (2012), 4870–4875.
27. [27] Ahmad, S., Khan, Z., Hagen, F., Meis, J.F., Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res 133 (2014), 20–26.
28. [28] Warris, A., Klaassen, C.H.W., Meis, J.F., de Ruiter, M.T., de Valk, H.A., Abrahamsen, T.G., et al. Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains. J Clin Microbiol 41 (2003), 4101–4106.
29. [29] Escribano, P., Recio, S., Peláez, T., Bouza, E., Guinea, J., Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole. Antimicrob Agents Chemother 55 (2011), 2460–2462.
30. [30] Guinea, J., García de Viedma, D., Peláez, T., Escribano, P., Muñoz, P., Meis, J.F., et al. Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis. J Clin Microbiol 49 (2011), 3498–3503.
31. [31] Howard, S.J., Cerar, D., Anderson, M.J., Albarrag, A., Fischer, M.C., Pasqualotto, A.C., et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15 (2009), 1068–1076.
32. [32] Verweij, P.E., Howard, S.J., Melchers, W.J.G., Denning, D.W., Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 12 (2009), 141–147.
33. [33] Camps, S.M.T., Rijs, A.J.M.M., Klaassen, C.H.W., Meis, J.F., O'Gorman, C.M., Dyer, P.S., et al. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism. J Clin Microbiol 50 (2012), 2674–2680.